As per the latest report by IMARC Group, titled "Lignans Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," the global lignans market is expected to exhibit a growth rate (CAGR) of 6.2% during 2024-2032. Lignans are a group of natural compounds found in plants that offer a range of health benefits. They are formed through lignification, which occurs when plants convert simple molecules into lignin, a complex polymer that provides structural support. Lignans are derived from the breakdown of lignin in the human body or through the consumption of lignan-rich foods, such as flaxseeds, sesame seeds, and whole grains. Once ingested, lignans are metabolized by intestinal bacteria into active compounds, such as enterolignans, which exert various biological effects. They are known for their antioxidant and phytoestrogenic properties, which enable them to scavenge harmful free radicals and mimic or modulate the action of estrogen in the body. These characteristics contribute to their potential health benefits, including reducing the risk of cardiovascular disease, cancer, and menopausal symptoms. There are several types of lignans available in the market, including secoisolariciresinol, matairesinol, pinoresinol, lariciresinol, and enterolignans, such as enterodiol and enterolactone.
Global Lignans Market Trends:
The surging consumer awareness regarding the health benefits of lignans is one of the key factors creating a positive outlook for the market. Additionally, the growing demand for natural and plant-based ingredients in the food and beverage (F&B) industry and the rising popularity of functional foods and dietary supplements are propelling the market growth. In confluence with this, the surging product application in the pharmaceutical and cosmetics and personal care industries are favoring the market growth. The burgeoning research and development (R&D) activities focused on exploring the therapeutic potential of lignans and the growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer, are acting as other factors influencing the market growth. Apart from this, the escalating interest in preventive healthcare measures, inflating disposable incomes, and changing consumer preferences toward natural and organic products are fueling the market growth. Other factors, such as the easy availability of lignan-rich plant sources, the expansion of distribution channels, including e-commerce platforms, and favorable government regulations and policies promoting natural ingredients, are facilitating the market growth.
Market Summary:
- By the source, the market is segregated into oilseeds, cereals and grains, and plant resins.
- Based on the application, the market is divided into food and beverages (functional foods, functional beverages, dietary supplements, and others), cosmetics and toiletries (haircare, skincare, toiletries, and others), pharmaceuticals, animal nutrition, and others.
- On the basis of the region, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the industry has also been examined with some of the key players being BioGin Biochemicals Co. Ltd., FarmaSino Pharmaceuticals (Jiangsu) Co. Ltd., Hebei Xinqidian Biotechnology Co. Ltd., Kingherbs Limited, Naturalin Bio-Resources Co. Ltd., Plamed Green Science Group, Prairie Tide Diversified Inc., Zebrago Industrial Co. Limited and SPI Pharma.
Report Scope:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Segment Coverage |
Source, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
BioGin Biochemicals Co. Ltd., FarmaSino Pharmaceuticals (Jiangsu) Co. Ltd., Hebei Xinqidian Biotechnology Co. Ltd., Kingherbs Limited, Naturalin Bio-Resources Co. Ltd., Plamed Green Science Group, Prairie Tide Diversified Inc., Zebrago Industrial Co. Limited and SPI Pharma |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800